Impact of Diabetes on Coronary Plaque Stabilization With Evolocumab: Insights From the YELLOW III Trial
- DOI
- 10.1007/s10557-026-07962-8
- Published
- 2026-09-24
- Container
- Cardiovascular Drugs and Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s10557-026-07962-8,
title = {Impact of Diabetes on Coronary Plaque Stabilization With Evolocumab: Insights From the YELLOW III Trial},
author = {Keisuke Yasumura and Yuliya Vengrenyuk and Jiajia Liu and Pruthvi C. Revaiah and Amit Hooda and Raman Sharma and Sahil Khera and Vishal Kapur and Joseph Sweeny and Prakash Krishnan and Pedro Moreno and Xiaobo Zhou and Jagat Narula and Roxana Mehran and Samin Sharma and Annapoorna S. Kini},
year = {2026},
journal = {Cardiovascular Drugs and Therapy},
doi = {10.1007/s10557-026-07962-8},
url = {https://doi.org/10.1007/s10557-026-07962-8}
}RIS
TY - JOUR TI - Impact of Diabetes on Coronary Plaque Stabilization With Evolocumab: Insights From the YELLOW III Trial AU - Keisuke Yasumura AU - Yuliya Vengrenyuk AU - Jiajia Liu AU - Pruthvi C. Revaiah AU - Amit Hooda AU - Raman Sharma AU - Sahil Khera AU - Vishal Kapur AU - Joseph Sweeny AU - Prakash Krishnan AU - Pedro Moreno AU - Xiaobo Zhou AU - Jagat Narula AU - Roxana Mehran AU - Samin Sharma AU - Annapoorna S. Kini PY - 2026 JO - Cardiovascular Drugs and Therapy DO - 10.1007/s10557-026-07962-8 UR - https://doi.org/10.1007/s10557-026-07962-8 ER -
APA
Yasumura, K., Vengrenyuk, Y., Liu, J., Revaiah, P. C., Hooda, A., Sharma, R., Khera, S., Kapur, V., Sweeny, J., Krishnan, P., Moreno, P., Zhou, X., Narula, J., Mehran, R., Sharma, S., & Kini, A. S. (2026). Impact of Diabetes on Coronary Plaque Stabilization With Evolocumab: Insights From the YELLOW III Trial. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-026-07962-8
Source records
- crossref · retrieved 2026-09-25T17:03:39.533Z